GUOLIN TECHNOLOGY(SZ:300786)2026-01-29 10:32Financial Performance Forecast - The company expects a net profit of approximately -23 million yuan for 2025, compared to -17 million yuan in the same period last year and -49.96 million yuan in 2024[5]. - The net profit after deducting non-recurring gains and losses is projected to be -30 million yuan, compared to -24 million yuan in the same period last year and -54.83 million yuan in 2024[5]. - The company anticipates that non-recurring gains and losses will impact net profit by approximately 7 million yuan in 2025[10]. - The performance forecast is preliminary and unaudited, with detailed financial data to be disclosed in the 2025 annual report[11]. Subsidiary Performance - The subsidiary, Qingdao Guolin Health Technology Co., Ltd., is in the market expansion and new product development phase, resulting in low sales volume and high costs, which negatively affects profits[10]. - The subsidiary, Xinjiang Guolin New Materials Co., Ltd., is expected to see an increase in production and sales in 2025 compared to 2024, but competitive pressure has kept product prices low, limiting loss reduction[10]. - The subsidiary, Qingdao Guolin Semiconductor Technology Co., Ltd., is expected to turn a profit in 2025, positively impacting consolidated financial performance, although its overall scale is relatively small[10]. Financial Management and Strategy - The company has communicated with its auditing firm regarding the performance forecast, and there are no significant discrepancies in the financial data[6]. - The increase in accounts receivable aging has led to the provision for impairment of accounts receivable, impacting the current net profit[8]. - The company aims to enhance management, reduce production costs, and improve accounts receivable recovery to drive high-quality development and profitability[10].